This interactive master class explores the expanding spectrum of antibodies in myasthenia gravis and their associated clinical phenotypes. The session will discuss how established and newly identified antibodies contribute to disease presentation, diagnosis, and management of muscle and neuromuscular junction disorders:
Date: 30 April 2026
Time: 15:00-16:00 (CEST)
Speaker: Christiane Schneider-Gold
This interactive master class is supported by an independent educational grant from argenX.
Registration is open to everyone with a MyEAN account. EAN membership is not required to attend the webinar. If you do not already have a myEAN account, you can create one here: https://my.ean.org.
For more information and to register, please click the LINK
_____________________________
